Stefan Schewe

Persistent clinical efficacy and safety of anti-tumour necrosis factor α therapy with infliximab in patients with ankylosing spondylitis over 5 years: evidence for different types of response

Jürgen Braun, Xenofon Baraliakos, Joachim Listing et al. · Annals of the Rheumatic Diseases · 2007 · 149 citations · Full text

Medicine, Immunology, Internal Medicine +13

Persistent clinical efficacy and safety of infliximab in ankylosing spondylitis after 8 years--early clinical response predicts long-term outcome

Xenofon Baraliakos, Joachim Listing, C. Fritz et al. · Lara D. Veeken · 2011 · 117 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +16

Whole-body MR imaging in psoriatic arthritis: Additional value for therapeutic decision making

Sabine Weckbach, Stefan Schewe, Henrik J. Michaely et al. · European Journal of Radiology · 2009 · 94 citations · Full text

Medicine, Clinical Sciences, Radiology +13

Transcript profiling of <scp>CD</scp>16‐positive monocytes reveals a unique molecular fingerprint

Marion Frankenberger, Thomas P. Hofer, Ayman Marei et al. · European Journal of Immunology · 2012 · 92 citations

Life Sciences, Cell Biology, Immunology +13

The European ankylosing spondylitis infliximab cohort (EASIC): a European multicentre study of long term outcomes in patients with ankylosing spondylitis treated with infliximab.

F. Heldmann, J. Brandt, Irene E. van der Horst‐Bruinsma et al. · PubMed · 2011 · 59 citations

Medicine, Clinical Sciences, Internal Medicine +6